Long-term assessment of health issues in COVID-19 survivors
Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment
This study is trying to see how COVID-19 affects the long-term health of people who were treated in sub-intensive care units after their infection.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of L'Aquila Academic / other |
| Locations | 2 sites (L'Aquila, Italy/L'Aquila and 1 other locations) |
| Trial ID | NCT05359159 on ClinicalTrials.gov |
What this trial studies
This observational study aims to follow patients who have previously been infected with SARS-CoV-2 to assess long-term health effects. It focuses on individuals discharged from sub-intensive care units, tracking the persistence and frequency of new or ongoing symptoms associated with COVID-19. By collecting data over time, the study seeks to better understand the post-infectious phase and the impact of long-COVID on patients' health.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 who have recovered from a SARS-CoV-2 infection.
Not a fit: Patients under 18 years old will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term effects of COVID-19, helping to improve patient care and management strategies.
How similar studies have performed: Other studies have shown varying degrees of success in understanding long-COVID, but this specific approach to long-term damage assessment is still being explored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 18 Exclusion Criteria: * Patients under 18
Where this trial is running
L'Aquila, Italy/L'Aquila and 1 other locations
- Clara Balsano — L'Aquila, Italy/L'Aquila, Italy (Recruiting)
- University of L'Aquila — L'Aquila, Italy (Recruiting)
Study contacts
- Study coordinator: Clara Balsano
- Email: clara.balsano@univaq.it
- Phone: 00390862434774
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.